A175 CAN HCV CORE ANTIGEN REPLACE HCV RNA TESTING IN THE ERA OF DIRECT-ACTING ANTIVIRALS?

BACKGROUND: Potent direct-acting antivirals (DAAs) for treatment of chronic hepatitis C virus (HCV) infection have reduced the need for on-treatment monitoring. Currently, on-treatment response and outcome are determined by HCV RNA testing. A less expensive alternative to verify viral replication is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Can Assoc Gastroenterol
Main Authors: Almarzooqi, S, van Tilborg, M, Maan, R, Vermehren, J, Maasoumy, B, Mazzulli, T, Duarte-Rojo, A, Kowgier, M, Janssen, H L, de Knegt, R, Pawlotsky, J, Cloherty, G, Sarrazin, C, Wedemeyer, H, Feld, J
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Poster Presentations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507833/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.176
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados